SB 951 is a broad health care governance bill aimed at limiting corporate and management-services control over medical practice in Oregon. It codifies and expands restrictions on management services organizations (MSOs) and other non-licensed entities so they cannot own or control a majority interest in certain professional medical entities, cannot exercise de facto control over clinical or business decisions that affect care, and cannot use contracts to direct hiring, staffing, scheduling, billing, pricing, payor negotiations, or other core operational decisions in ways that interfere with medical judgment. The bill also makes contract provisions that violate these limits void and unenforceable, and it creates a private right of action for affected medical licensees or professional medical entities to seek damages, injunctions, equitable relief, punitive damages, and attorney fees.
The bill also revises Oregon’s professional corporation statutes for physician-only practices, physician associate/nurse practitioner joint practices, and naturopathic medicine practices. It requires licensed practitioners to hold majority voting shares and board control in those entities, limits who may serve as officers, and restricts transfer or relinquishment of control except through agreements among licensed majority owners. SB 951 includes exemptions and carveouts for certain entities and settings, including some nonprofit and underserved-population providers, rural health clinics, telemedicine entities without in-state patient-facing physical locations, coordinated care organizations with preexisting arrangements, and several behavioral health, hospital, long-term care, residential care, PACE, tribal, and crisis-line providers. It also bars most noncompetition, nondisclosure, and nondisparagement agreements involving medical licensees and MSOs, hospitals, or hospital-affiliated clinics, while preserving limited enforceability in specified ownership, settlement, and post-hire circumstances.
The bill’s impact on state law is significant because it amends ORS 58.375 and 58.376 and adds new provisions to Oregon’s labor and corporate law framework governing medical practices. It creates new statutory definitions for MSOs, professional medical entities, medical licensees, and related terms; invalidates conflicting contract terms; and establishes enforcement mechanisms against improper corporate influence in medicine. The law applies immediately upon passage because of the emergency clause, but some of the MSO ownership/control restrictions are phased in later for existing entities, with different effective dates for newly formed versus preexisting organizations.
Overall sentiment appears generally favorable but not unanimous. The bill advanced through both chambers with clear majority support, including strong third-reading votes in the Senate and House, suggesting broad legislative agreement with the goal of protecting clinician independence and patient-centered care. At the committee stage, however, the narrower vote margins and the failed Senate motion to substitute a minority report indicate meaningful opposition or concern from some members.
The main points of contention likely center on how far the bill goes in regulating private health care business arrangements. Supporters appear to view the measure as necessary to stop corporate interference, protect whistleblowing, and preserve medical judgment. Opponents or skeptics likely worry about the bill’s breadth, its restrictions on MSO ownership and control, the limits on noncompete and confidentiality agreements, and the potential compliance burden or disruption for existing health care business structures, especially those with preexisting management contracts or integrated delivery models.
SB 951 substantially changes Oregon law governing the ownership, governance, and management of medical practices by non-licensed entities. It amends ORS 58.375 and 58.376 to reinforce physician, physician associate, nurse practitioner, and naturopathic physician control over professional corporations, and it adds new statutory rules that restrict management services organizations from owning, controlling, or directing professional medical entities in ways that affect clinical decision-making. The bill also voids conflicting contract provisions, creates civil remedies for violations, and limits the enforceability of noncompetition, nondisclosure, and nondisparagement agreements in the health care context, while preserving specified exemptions and transition periods for certain entities and preexisting arrangements.
The overall legislative sentiment was supportive of the bill’s core purpose of protecting medical autonomy and limiting corporate influence in health care. The bill passed both chambers with comfortable margins on final reading, indicating broad approval. At the same time, the committee vote history and the failed minority-report motion suggest there was real disagreement about the scope and practical effects of the restrictions, particularly among members concerned about business operations, existing contracts, and exemptions.
The most notable contention is between supporters who argue that corporate and MSO control can undermine patient care and physician judgment, and critics who likely see the bill as overbroad or disruptive to existing health care delivery models. Specific flashpoints include the ban on de facto control over staffing, pricing, billing, and payor negotiations; the limits on ownership and transfer restrictions; the invalidation of noncompete, NDA, and nondisparagement clauses; and the phased application to existing entities. Exemptions for hospitals, rural clinics, behavioral health providers, telemedicine, and coordinated care organizations also suggest lawmakers were balancing the bill’s anti-corporate goals against concerns about operational feasibility in specialized or underserved settings.